Global Parkinson’s Disease Therapeutics Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Parkinson’s Disease Therapeutics Market Size 2017-2028

2.1.2 Parkinson’s Disease Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Parkinson’s Disease Therapeutics Segment by Type

2.2.1 Oral

2.2.2 Transdermal

2.2.3 Subcutaneous

2.2.4 Intestinal Infusion

2.3 Parkinson’s Disease Therapeutics Market Size by Type

2.3.1 Parkinson’s Disease Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Parkinson’s Disease Therapeutics Market Size Market Share by Type (2017-2022)

2.4 Parkinson’s Disease Therapeutics Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Others

2.5 Parkinson’s Disease Therapeutics Market Size by Application

2.5.1 Parkinson’s Disease Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Parkinson’s Disease Therapeutics Market Size Market Share by Application (2017-2022)

3 Parkinson’s Disease Therapeutics Market Size by Player

3.1 Parkinson’s Disease Therapeutics Market Size Market Share by Players

3.1.1 Global Parkinson’s Disease Therapeutics Revenue by Players (2020-2022)

3.1.2 Global Parkinson’s Disease Therapeutics Revenue Market Share by Players (2020-2022)

3.2 Global Parkinson’s Disease Therapeutics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Parkinson’s Disease Therapeutics by Regions

4.1 Parkinson’s Disease Therapeutics Market Size by Regions (2017-2022)

4.2 Americas Parkinson’s Disease Therapeutics Market Size Growth (2017-2022)

4.3 APAC Parkinson’s Disease Therapeutics Market Size Growth (2017-2022)

4.4 Europe Parkinson’s Disease Therapeutics Market Size Growth (2017-2022)

4.5 Middle East & Africa Parkinson’s Disease Therapeutics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Parkinson’s Disease Therapeutics Market Size by Country (2017-2022)

5.2 Americas Parkinson’s Disease Therapeutics Market Size by Type (2017-2022)

5.3 Americas Parkinson’s Disease Therapeutics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Parkinson’s Disease Therapeutics Market Size by Region (2017-2022)

6.2 APAC Parkinson’s Disease Therapeutics Market Size by Type (2017-2022)

6.3 APAC Parkinson’s Disease Therapeutics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Parkinson’s Disease Therapeutics by Country (2017-2022)

7.2 Europe Parkinson’s Disease Therapeutics Market Size by Type (2017-2022)

7.3 Europe Parkinson’s Disease Therapeutics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Parkinson’s Disease Therapeutics by Region (2017-2022)

8.2 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Type (2017-2022)

8.3 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Parkinson’s Disease Therapeutics Market Forecast

10.1 Global Parkinson’s Disease Therapeutics Forecast by Regions (2023-2028)

10.1.1 Global Parkinson’s Disease Therapeutics Forecast by Regions (2023-2028)

10.1.2 Americas Parkinson’s Disease Therapeutics Forecast

10.1.3 APAC Parkinson’s Disease Therapeutics Forecast

10.1.4 Europe Parkinson’s Disease Therapeutics Forecast

10.1.5 Middle East & Africa Parkinson’s Disease Therapeutics Forecast

10.2 Americas Parkinson’s Disease Therapeutics Forecast by Country (2023-2028)

10.2.1 United States Parkinson’s Disease Therapeutics Market Forecast

10.2.2 Canada Parkinson’s Disease Therapeutics Market Forecast

10.2.3 Mexico Parkinson’s Disease Therapeutics Market Forecast

10.2.4 Brazil Parkinson’s Disease Therapeutics Market Forecast

10.3 APAC Parkinson’s Disease Therapeutics Forecast by Region (2023-2028)

10.3.1 China Parkinson’s Disease Therapeutics Market Forecast

10.3.2 Japan Parkinson’s Disease Therapeutics Market Forecast

10.3.3 Korea Parkinson’s Disease Therapeutics Market Forecast

10.3.4 Southeast Asia Parkinson’s Disease Therapeutics Market Forecast

10.3.5 India Parkinson’s Disease Therapeutics Market Forecast

10.3.6 Australia Parkinson’s Disease Therapeutics Market Forecast

10.4 Europe Parkinson’s Disease Therapeutics Forecast by Country (2023-2028)

10.4.1 Germany Parkinson’s Disease Therapeutics Market Forecast

10.4.2 France Parkinson’s Disease Therapeutics Market Forecast

10.4.3 UK Parkinson’s Disease Therapeutics Market Forecast

10.4.4 Italy Parkinson’s Disease Therapeutics Market Forecast

10.4.5 Russia Parkinson’s Disease Therapeutics Market Forecast

10.5 Middle East & Africa Parkinson’s Disease Therapeutics Forecast by Region (2023-2028)

10.5.1 Egypt Parkinson’s Disease Therapeutics Market Forecast

10.5.2 South Africa Parkinson’s Disease Therapeutics Market Forecast

10.5.3 Israel Parkinson’s Disease Therapeutics Market Forecast

10.5.4 Turkey Parkinson’s Disease Therapeutics Market Forecast

10.5.5 GCC Countries Parkinson’s Disease Therapeutics Market Forecast

10.6 Global Parkinson’s Disease Therapeutics Forecast by Type (2023-2028)

10.7 Global Parkinson’s Disease Therapeutics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Abbvie

11.1.1 Abbvie Company Information

11.1.2 Abbvie Parkinson’s Disease Therapeutics Product Offered

11.1.3 Abbvie Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Abbvie Main Business Overview

11.1.5 Abbvie Latest Developments

11.2 Biogen

11.2.1 Biogen Company Information

11.2.2 Biogen Parkinson’s Disease Therapeutics Product Offered

11.2.3 Biogen Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Biogen Main Business Overview

11.2.5 Biogen Latest Developments

11.3 Boehringer Ingelheim GmbH

11.3.1 Boehringer Ingelheim GmbH Company Information

11.3.2 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Offered

11.3.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Boehringer Ingelheim GmbH Main Business Overview

11.3.5 Boehringer Ingelheim GmbH Latest Developments

11.4 F. Hoffman-La Roche

11.4.1 F. Hoffman-La Roche Company Information

11.4.2 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Offered

11.4.3 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 F. Hoffman-La Roche Main Business Overview

11.4.5 F. Hoffman-La Roche Latest Developments

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Information

11.5.2 GlaxoSmithKline Parkinson’s Disease Therapeutics Product Offered

11.5.3 GlaxoSmithKline Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 GlaxoSmithKline Main Business Overview

11.5.5 GlaxoSmithKline Latest Developments

11.6 H. Lundbeck A/S

11.6.1 H. Lundbeck A/S Company Information

11.6.2 H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Offered

11.6.3 H. Lundbeck A/S Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 H. Lundbeck A/S Main Business Overview

11.6.5 H. Lundbeck A/S Latest Developments

11.7 Impax Labs

11.7.1 Impax Labs Company Information

11.7.2 Impax Labs Parkinson’s Disease Therapeutics Product Offered

11.7.3 Impax Labs Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Impax Labs Main Business Overview

11.7.5 Impax Labs Latest Developments

11.8 Newron Pharmaceuticals SpA

11.8.1 Newron Pharmaceuticals SpA Company Information

11.8.2 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Offered

11.8.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Newron Pharmaceuticals SpA Main Business Overview

11.8.5 Newron Pharmaceuticals SpA Latest Developments

11.9 Novartis AG

11.9.1 Novartis AG Company Information

11.9.2 Novartis AG Parkinson’s Disease Therapeutics Product Offered

11.9.3 Novartis AG Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Novartis AG Main Business Overview

11.9.5 Novartis AG Latest Developments

11.10 Orion Corporation

11.10.1 Orion Corporation Company Information

11.10.2 Orion Corporation Parkinson’s Disease Therapeutics Product Offered

11.10.3 Orion Corporation Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Orion Corporation Main Business Overview

11.10.5 Orion Corporation Latest Developments

11.11 Teva Pharmaceutical Industries Ltd.

11.11.1 Teva Pharmaceutical Industries Ltd. Company Information

11.11.2 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Offered

11.11.3 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Teva Pharmaceutical Industries Ltd. Main Business Overview

11.11.5 Teva Pharmaceutical Industries Ltd. Latest Developments

11.12 UCB S.A.

11.12.1 UCB S.A. Company Information

11.12.2 UCB S.A. Parkinson’s Disease Therapeutics Product Offered

11.12.3 UCB S.A. Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 UCB S.A. Main Business Overview

11.12.5 UCB S.A. Latest Developments

11.13 Livzon Pharmaceutical

11.13.1 Livzon Pharmaceutical Company Information

11.13.2 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Offered

11.13.3 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Livzon Pharmaceutical Main Business Overview

11.13.5 Livzon Pharmaceutical Latest Developments

11.14 Haisco Pharmaceutical

11.14.1 Haisco Pharmaceutical Company Information

11.14.2 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Offered

11.14.3 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Haisco Pharmaceutical Main Business Overview

11.14.5 Haisco Pharmaceutical Latest Developments

11.15 Jingxin Pharmaceutical

11.15.1 Jingxin Pharmaceutical Company Information

11.15.2 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Offered

11.15.3 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Jingxin Pharmaceutical Main Business Overview

11.15.5 Jingxin Pharmaceutical Latest Developments

11.16 Dongcheng Biochemicals

11.16.1 Dongcheng Biochemicals Company Information

11.16.2 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Offered

11.16.3 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Dongcheng Biochemicals Main Business Overview

11.16.5 Dongcheng Biochemicals Latest Developments

12 Research Findings and Conclusion

Table 1. Parkinson’s Disease Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Oral

Table 3. Major Players of Transdermal

Table 4. Major Players of Subcutaneous

Table 5. Major Players of Intestinal Infusion

Table 6. Parkinson’s Disease Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Parkinson’s Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Parkinson’s Disease Therapeutics Market Size Market Share by Type (2017-2022)

Table 9. Parkinson’s Disease Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Parkinson’s Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Parkinson’s Disease Therapeutics Market Size Market Share by Application (2017-2022)

Table 12. Global Parkinson’s Disease Therapeutics Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Parkinson’s Disease Therapeutics Revenue Market Share by Player (2020-2022)

Table 14. Parkinson’s Disease Therapeutics Key Players Head office and Products Offered

Table 15. Parkinson’s Disease Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Parkinson’s Disease Therapeutics Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Parkinson’s Disease Therapeutics Market Size Market Share by Regions (2017-2022)

Table 20. Americas Parkinson’s Disease Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Parkinson’s Disease Therapeutics Market Size Market Share by Country (2017-2022)

Table 22. Americas Parkinson’s Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Parkinson’s Disease Therapeutics Market Size Market Share by Type (2017-2022)

Table 24. Americas Parkinson’s Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Parkinson’s Disease Therapeutics Market Size Market Share by Application (2017-2022)

Table 26. APAC Parkinson’s Disease Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Parkinson’s Disease Therapeutics Market Size Market Share by Region (2017-2022)

Table 28. APAC Parkinson’s Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Parkinson’s Disease Therapeutics Market Size Market Share by Type (2017-2022)

Table 30. APAC Parkinson’s Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Parkinson’s Disease Therapeutics Market Size Market Share by Application (2017-2022)

Table 32. Europe Parkinson’s Disease Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Parkinson’s Disease Therapeutics Market Size Market Share by Country (2017-2022)

Table 34. Europe Parkinson’s Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Parkinson’s Disease Therapeutics Market Size Market Share by Type (2017-2022)

Table 36. Europe Parkinson’s Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Parkinson’s Disease Therapeutics Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Parkinson’s Disease Therapeutics Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Parkinson’s Disease Therapeutics Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Parkinson’s Disease Therapeutics Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Parkinson’s Disease Therapeutics

Table 45. Key Market Challenges & Risks of Parkinson’s Disease Therapeutics

Table 46. Key Industry Trends of Parkinson’s Disease Therapeutics

Table 47. Global Parkinson’s Disease Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Parkinson’s Disease Therapeutics Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Parkinson’s Disease Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Parkinson’s Disease Therapeutics Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Parkinson’s Disease Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Parkinson’s Disease Therapeutics Market Size Market Share Forecast by Application (2023-2028)

Table 53. Abbvie Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors

Table 54. Abbvie Parkinson’s Disease Therapeutics Product Offered

Table 55. Abbvie Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Abbvie Main Business

Table 57. Abbvie Latest Developments

Table 58. Biogen Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors

Table 59. Biogen Parkinson’s Disease Therapeutics Product Offered

Table 60. Biogen Main Business

Table 61. Biogen Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Biogen Latest Developments

Table 63. Boehringer Ingelheim GmbH Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors

Table 64. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Offered

Table 65. Boehringer Ingelheim GmbH Main Business

Table 66. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Boehringer Ingelheim GmbH Latest Developments

Table 68. F. Hoffman-La Roche Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors

Table 69. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Offered

Table 70. F. Hoffman-La Roche Main Business

Table 71. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. F. Hoffman-La Roche Latest Developments

Table 73. GlaxoSmithKline Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors

Table 74. GlaxoSmithKline Parkinson’s Disease Therapeutics Product Offered

Table 75. GlaxoSmithKline Main Business

Table 76. GlaxoSmithKline Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. GlaxoSmithKline Latest Developments

Table 78. H. Lundbeck A/S Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors

Table 79. H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Offered

Table 80. H. Lundbeck A/S Main Business

Table 81. H. Lundbeck A/S Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. H. Lundbeck A/S Latest Developments

Table 83. Impax Labs Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors

Table 84. Impax Labs Parkinson’s Disease Therapeutics Product Offered

Table 85. Impax Labs Main Business

Table 86. Impax Labs Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. Impax Labs Latest Developments

Table 88. Newron Pharmaceuticals SpA Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors

Table 89. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Offered

Table 90. Newron Pharmaceuticals SpA Main Business

Table 91. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Newron Pharmaceuticals SpA Latest Developments

Table 93. Novartis AG Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors

Table 94. Novartis AG Parkinson’s Disease Therapeutics Product Offered

Table 95. Novartis AG Main Business

Table 96. Novartis AG Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. Novartis AG Latest Developments

Table 98. Orion Corporation Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors

Table 99. Orion Corporation Parkinson’s Disease Therapeutics Product Offered

Table 100. Orion Corporation Main Business

Table 101. Orion Corporation Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. Orion Corporation Latest Developments

Table 103. Teva Pharmaceutical Industries Ltd. Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors

Table 104. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Offered

Table 105. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. Teva Pharmaceutical Industries Ltd. Main Business

Table 107. Teva Pharmaceutical Industries Ltd. Latest Developments

Table 108. UCB S.A. Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors

Table 109. UCB S.A. Parkinson’s Disease Therapeutics Product Offered

Table 110. UCB S.A. Main Business

Table 111. UCB S.A. Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 112. UCB S.A. Latest Developments

Table 113. Livzon Pharmaceutical Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors

Table 114. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Offered

Table 115. Livzon Pharmaceutical Main Business

Table 116. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 117. Livzon Pharmaceutical Latest Developments

Table 118. Haisco Pharmaceutical Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors

Table 119. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Offered

Table 120. Haisco Pharmaceutical Main Business

Table 121. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 122. Haisco Pharmaceutical Latest Developments

Table 123. Jingxin Pharmaceutical Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors

Table 124. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Offered

Table 125. Jingxin Pharmaceutical Main Business

Table 126. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 127. Jingxin Pharmaceutical Latest Developments

Table 128. Dongcheng Biochemicals Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors

Table 129. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Offered

Table 130. Dongcheng Biochemicals Main Business

Table 131. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 132. Dongcheng Biochemicals Latest Developments

List of Figures

Figure 1. Parkinson’s Disease Therapeutics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Parkinson’s Disease Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Parkinson’s Disease Therapeutics Market Size Market Share by Type in 2021

Figure 7. Parkinson’s Disease Therapeutics in Hospitals

Figure 8. Global Parkinson’s Disease Therapeutics Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Parkinson’s Disease Therapeutics in Clinics

Figure 10. Global Parkinson’s Disease Therapeutics Market: Clinics (2017-2022) & ($ Millions)

Figure 11. Parkinson’s Disease Therapeutics in Others

Figure 12. Global Parkinson’s Disease Therapeutics Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Parkinson’s Disease Therapeutics Market Size Market Share by Application in 2021

Figure 14. Global Parkinson’s Disease Therapeutics Revenue Market Share by Player in 2021

Figure 15. Global Parkinson’s Disease Therapeutics Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Parkinson’s Disease Therapeutics Market Size 2017-2022 ($ Millions)

Figure 17. APAC Parkinson’s Disease Therapeutics Market Size 2017-2022 ($ Millions)

Figure 18. Europe Parkinson’s Disease Therapeutics Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Parkinson’s Disease Therapeutics Market Size 2017-2022 ($ Millions)

Figure 20. Americas Parkinson’s Disease Therapeutics Value Market Share by Country in 2021

Figure 21. Americas Parkinson’s Disease Therapeutics Consumption Market Share by Type in 2021

Figure 22. Americas Parkinson’s Disease Therapeutics Market Size Market Share by Application in 2021

Figure 23. United States Parkinson’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Parkinson’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Parkinson’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Parkinson’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Parkinson’s Disease Therapeutics Market Size Market Share by Region in 2021

Figure 28. APAC Parkinson’s Disease Therapeutics Market Size Market Share by Application in 2021

Figure 29. China Parkinson’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Parkinson’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Parkinson’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Parkinson’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Parkinson’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Parkinson’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Parkinson’s Disease Therapeutics Market Size Market Share by Country in 2021

Figure 36. Europe Parkinson’s Disease Therapeutics Market Size Market Share by Type in 2021

Figure 37. Europe Parkinson’s Disease Therapeutics Market Size Market Share by Application in 2021

Figure 38. Germany Parkinson’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Parkinson’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Parkinson’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Parkinson’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Parkinson’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Parkinson’s Disease Therapeutics Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Parkinson’s Disease Therapeutics Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Parkinson’s Disease Therapeutics Market Size Market Share by Application in 2021

Figure 46. Egypt Parkinson’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Parkinson’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Parkinson’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Parkinson’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Parkinson’s Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 52. APAC Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 53. Europe Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 55. United States Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 56. Canada Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 59. China Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 60. Japan Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 61. Korea Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 63. India Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 64. Australia Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 65. Germany Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 66. France Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 67. UK Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 68. Italy Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 69. Russia Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 70. Spain Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 73. Israel Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Parkinson’s Disease Therapeutics Market Size 2023-2028 ($ Millions)